NCT04872361

Brief Summary

Ventilated Patients especially those undergoing upper abdominal surgeries are prone to lung atelectasis. They are at risk of adverse effects secondary to inadequate lung ventilation. Applied PEEP and Recruitment maneuver are thought to enhance lung aeration under general anesthesia which could be assessed by ultrasound.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
117

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 4, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

May 4, 2021

Status Verified

May 1, 2021

Enrollment Period

1.1 years

First QC Date

May 2, 2021

Last Update Submit

May 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pre-emergence LUS score

    Lung ultrasonography score (LUS score) between groups at the end of surgery (just before emergence) as a lower LUS indicates better lung aeration.

    intraoperative before recovery from anesthesia

Secondary Outcomes (10)

  • Lung ultrasonography score (LUS score)

    preoperative, intraoperative for anesthesia duration to 1 hour postoperative

  • Heart rate

    preoperative, intraoperative for anesthesia duration to 1 hour postoperative

  • Mean blood pressure

    preoperative, intraoperative to 1 hour postoperative

  • oxygen saturation

    preoperative, intraoperative to 1 hour postoperative

  • End-tidal carbon dioxide tension

    intraoperative for anesthesia duration

  • +5 more secondary outcomes

Study Arms (3)

Low PEEP

PLACEBO COMPARATOR

Low positive end-expiratory pressure (PEEP) and no recruitment maneuver (RM)

Procedure: Low PEEPDevice: Lung ultrasonogrphy assessment

High PEEP

ACTIVE COMPARATOR

High positive end-expiratory pressure (PEEP)

Procedure: High PEEPDevice: Lung ultrasonogrphy assessment

High PEEP/RM

ACTIVE COMPARATOR

High positive end-expiratory pressure (PEEP) and recruitment maneuver (RM)

Procedure: High PEEP/RMDevice: Lung ultrasonogrphy assessment

Interventions

Low PEEPPROCEDURE

Patients will be ventilated with a PEEP of 4 cm H2O and no RMs throughout the study

Low PEEP
High PEEPPROCEDURE

PEEP of 10 cm H2O will be applied

High PEEP
High PEEP/RMPROCEDURE

PEEP of 10 cm H2O and RM (30 cm H2O for 30 s) immediately after the second lung ultrasonographic examination and repeated every 30 minutes till emergence

High PEEP/RM

The thorax will divided into 12 quadrants, each of them will be assigned a score of 0-3 as 0, normal lung sliding with fewer than three single B lines 1. three or more B lines 2. coalescent B lines 3. consolidated lung. The LUS (0-36) will be calculated with higher scores indicating more aeration loss

High PEEPHigh PEEP/RMLow PEEP

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists' physical status grades I, II, and III.

You may not qualify if:

  • Patient refusal.
  • Psychiatric diseases.
  • Body Mass Index \> 35 Kg/m2.
  • Previous intrathoracic procedures.
  • History of severe obstructive pulmonary disease.
  • History of severe restrictive lung disease.
  • Pulmonary arterial hypertension ( systolic pulmonary arterial pressure \>40 mmHg).
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, DK, 050, Egypt

Location

Study Officials

  • Aboelnour E Badran, MD

    Professor of Anesthesia and Surgical Intensive Care

    STUDY CHAIR
  • Hanaa M EL- Bendary, MD

    Assistant Professor of Anesthesia and Surgical Intensive Care

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double-blind (Participant, Outcomes Assessor).
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2021

First Posted

May 4, 2021

Study Start

May 1, 2021

Primary Completion

June 1, 2022

Study Completion

October 1, 2022

Last Updated

May 4, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will share

will be available after completing the study and acceptance for publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
after completing the study and acceptance for publication
Access Criteria
Sharing Criteria: the data will be accessible to the investigators and PRS administrators with hiding the identifiers for the patients.

Locations